Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate Cancer

BACKGROUND: Safety is a central consideration when choosing between multiple medications with similar efficacy. We aimed to evaluate whether adverse event (AE) profiles of 3 such drugs in advanced prostate cancer could be distinguished based on published literature. METHODS: We assessed consistency...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Natl Cancer Inst
Hauptverfasser: Drago, Joshua Z, Gönen, Mithat, Thanarajasingam, Gita, Sacks, Chana A, Morris, Michael J, Kantoff, Philip W, Stopsack, Konrad H
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2020
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8096372/
https://ncbi.nlm.nih.gov/pubmed/32857839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa134
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge